Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);Application
Figure 1: Western blot analysis using MARK3 mAb against human MARK3 recombinant protein. (Expected MW is 40.8 kDa)Application
Figure 2: Western blot analysis using MARK3 mouse mAb against HeLa (1), SK-N-SH (2), K562 (3), HCT116 (4), HEK293 (5), 3T3L1 (6), NIH3T3 (7), Jurkat (8), and A431 (9) cell lysate.Application
Figure 3: Flow cytometric analysis of SK-N-SH cells using MARK3 mouse mAb (green) and negative control (red).Application
Figure 4: Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using MARK3 mouse mAb with DAB staining.| Product Name | MARK3 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | KP78; CTAK1; PAR1A; Par-1a |
| Immunogen | Purified recombinant fragment of human MARK3 (AA: 435-658) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouse |
| Alternative Names | KP78 CTAK1 PAR1A Par-1a |
|---|---|
| Molecular Weight(MW) | 87kDa |
| Entrez Gene | 4140 |
|---|
Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Application
Figure 1: Western blot analysis using MARK3 mAb against human MARK3 recombinant protein. (Expected MW is 40.8 kDa)
Application
Figure 2: Western blot analysis using MARK3 mouse mAb against HeLa (1), SK-N-SH (2), K562 (3), HCT116 (4), HEK293 (5), 3T3L1 (6), NIH3T3 (7), Jurkat (8), and A431 (9) cell lysate.
Application
Figure 3: Flow cytometric analysis of SK-N-SH cells using MARK3 mouse mAb (green) and negative control (red).
Application
Figure 4: Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using MARK3 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
